Risk factors of a reduced response to ranibizumab treatment for neovascular age-related macular degeneration – evaluation in a clinical setting

BACKGROUND: To identify risk factors for being a “reduced responder” to ranibizumab treatment in a clinical setting in patients with neovascular age-related macular degeneration. METHODS: This retrospective study included 165 eyes of 165 consecutive patients with choroidal neovascularisation seconda...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Korb, Christina, Zwiener, Isabella, Lorenz, Katrin, Mirshahi, Alireza, Pfeiffer, Norbert, Stoffelns, Bernhard
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3878195/
https://ncbi.nlm.nih.gov/pubmed/24359591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2415-13-84
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados